About
New drugs based on the modulation of adenosine receptors
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (53)
View allTotal Trials
53
As Lead Sponsor
43
As Collaborator
10
Total Enrollment
34,357
By Phase
PHASE3: 9PHASE2: 13PHASE1/PHASE2: 1PHASE4: 4NA: 2PHASE2/PHASE3: 6PHASE1: 12
By Status
COMPLETED: 45NOT_YET_RECRUITING: 4RECRUITING: 2WITHDRAWN: 1UNKNOWN: 1
Clinical Trials Pipeline53 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05482282Lead Sponsor
Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
PHASE3Withdrawn
Started: Dec 31, 2025 · Completed: Dec 31, 2026
NCT05482295Lead Sponsor
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
PHASE3Not yet recruiting
540 participants
Started: Sep 30, 2025 · Completed: May 31, 2026
NCT06895486Collaborator
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
PHASE2Not yet recruiting
675 participants
Started: Sep 29, 2025 · Completed: Nov 13, 2026
NCT06921460Lead Sponsor
Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV
N/ANot yet recruiting
624 participants
Started: Jun 15, 2025 · Completed: Dec 31, 2025
NCT06690515Lead Sponsor
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
PHASE1/PHASE2Not yet recruiting
465 participants
Started: Mar 1, 2025 · Completed: Sep 30, 2026
Locations (1)
Headquarters
Barcelona, Spain
Map
Loading map...